Bank of America’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.21M | Buy |
|
|||||
|
2025
Q2 | $10.8K | Sell |
|
|||||
|
2025
Q1 | $295K | Buy |
|
|||||
|
2024
Q4 | $2.08K | Sell |
|
|||||
|
2024
Q3 | $24.3K | Buy |
|
|||||
|
2024
Q2 | $7.01K | Sell |
|
|||||
|
2024
Q1 | $170K | Buy |
|
|||||
|
2023
Q4 | $27.6K | Sell |
|
|||||
|
2023
Q3 | $33K | Sell |
|
|||||
|
2023
Q2 | $53.8K | Sell |
|
|||||
|
2023
Q1 | $60.4K | Sell |
|
|||||
|
2022
Q4 | $67.2K | Buy |
|
|||||
|
2022
Q3 | $19K | Sell |
|
|||||
|
2022
Q2 | $34K | Buy |
|
|||||
|
2022
Q1 | $39K | Sell |
|
|||||
|
2021
Q4 | $221K | Buy |
|
|||||
|
2021
Q3 | $161K | Buy |
|
|||||
|
2021
Q2 | $158K | Sell |
|
|||||
|
2021
Q1 | $364K | Buy |
|
|||||
|
2020
Q4 | $140K | Sell |
|
|||||
|
2020
Q3 | $392K | Buy |
|
|||||
|
2020
Q2 | $259K | Buy |
|
|||||
|
2020
Q1 | $181K | Sell |
|
|||||
|
2019
Q4 | $237K | Sell |
|
|||||
|
2019
Q3 | $455K | Sell |
|
|||||
|
2019
Q2 | $1.13M | Sell |
|
|||||
|
2019
Q1 | $1.37M | Buy |
|
|||||
|
2018
Q4 | $839K | Buy |
|
|||||
|
2018
Q3 | $965K | Sell |
|
|||||
|
2018
Q2 | $2.94M | Sell |
|
|||||
|
2018
Q1 | $5.68M | Buy |
|
|||||
|
2017
Q4 | $2.56M | Buy |
|
|||||
|
2017
Q3 | $1.75M | Sell |
|
|||||
|
2017
Q2 | $1.63M | Buy |
|
|||||
|
2017
Q1 | $1.35M | Sell |
|
|||||
|
2016
Q4 | $1.3M | Buy |
|
|||||
|
2016
Q3 | $1.12M | Buy |
|
|||||
|
2016
Q2 | $33K | Buy |
|
|||||
|
2016
Q1 | $23K | Sell |
|
|||||
|
2015
Q4 | $42K | Buy |
|